Authority Atlas

Biotica helps family offices, emerging funds, syndicates, and regional investment groups convert scientific diligence into searchable, citation-backed assets that support both fund positioning and individual deal execution.

Authority Infrastructure for Capital Allocators

Make your diligence usable for both decisions and visibility.

Turn diligence into reusable authority assets.

Biotica converts complex scientific diligence into structured public/private authority assets that help funds communicate category expertise and help individual deals move faster with clearer evidence.

Many investors have strong judgment and domain conviction. Biotica helps make that expertise visibly legible both at the fund level and within each individual investment opportunity.

Most diligence is done once and reused poorly.

Investment teams often produce strong analysis, but it remains trapped in static memos and ad hoc threads. That makes it harder to reuse across LP updates, founder conversations, co-investor outreach, and future related deals.

  • High-quality diligence often has to be re-explained each time a new stakeholder enters the process.
  • LP, founder, and co-investor communication can diverge when there is no shared evidence system.
  • Individual deal diligence rarely becomes reusable infrastructure for the next opportunity.
  • Private memos are hard to update, hard to search, and difficult to operationalize across teams.
  • Search engines and AI agents can only discover expertise that is structured, published, and citation-backed.

Convert diligence into a structured operating asset.

Biotica runs AI-assisted, human-reviewed diligence and translates it into a citation-backed authority atlas with public and private layers. The same system supports fund-level thesis authority and deal-level underwriting communication.

  • Create one source of truth for scientific claims, risks, and investment implications.
  • Reduce repeated memo rewriting across deals in related categories.
  • Convert live deal diligence into reusable stakeholder-facing assets.
  • Improve LP, founder, and co-investor communication speed and consistency.
  • Build long-term GEO/SEO discoverability from work you are already doing.
  • Strengthen category association without sacrificing technical rigor.

Private diligence should not stay trapped in private documents.

A private memo may help one investment committee once. A Biotica Authority Atlas turns that work into a reusable evidence system: public pages for authority and discoverability, plus private layers for underwriting and decision support on individual deals.

One diligence system, two authority outcomes

Fund-level authority

Build category ownership and long-term GEO/SEO discoverability so your fund is associated with specific scientific niches.

  • Public thesis pages for priority sectors
  • Crawlable evidence maps that compound over time
  • LP and founder-facing narrative consistency

Deal-level authority

Convert diligence on individual opportunities into structured authority assets that strengthen conviction, communication, and syndication.

  • Deal-specific evidence rooms tied to one opportunity
  • Bull/base/bear framing with source-backed claims
  • Reusable co-investor and IC communication layer

Ideal customer profiles

Priority 1

Family Offices

Invest in complex science with a visible evidence base, not just conviction.

Core pain: They are expanding into technical opportunities and benefit from a visible life science evidence base.

Best offer: Life Science Thesis Atlas

Use case: A family office exploring longevity therapeutics, neuroinflammation, or extracellular vesicle investments wants a public/private diligence asset.

Buyer titles

PrincipalChief Investment OfficerInvestment DirectorFamily Office Advisor

Priority 2

Emerging Venture Funds

Own a niche before larger funds notice it.

Core pain: They need to communicate a differentiated thesis clearly while their track record is still maturing.

Best offer: Category Authority Atlas

Use case: A seed fund wants to become known for AI pathology, RNA delivery, or immune-mediated disease platforms.

Buyer titles

Managing PartnerGeneral PartnerPrincipalHead of Platform

Priority 3

SSBCI and Regional Innovation Funds

Show founders, policymakers, and co-investors why your regional ecosystem matters.

Core pain: They need to communicate ecosystem expertise, public legitimacy, and sector focus to diverse stakeholders.

Best offer: Regional Innovation Authority Atlas

Use case: A state-supported fund wants to map regional biotech, diagnostics, medtech, blue-tech, or advanced manufacturing opportunities.

Buyer titles

Fund DirectorEconomic Development LeadInnovation OfficerProgram Director

Priority 4

Angel Syndicates and Physician Investor Groups

Give your members a clearer reason to believe in a technical investment thesis.

Core pain: They need members and co-investors to quickly understand and trust their technical judgment.

Best offer: Syndicate Diligence Atlas

Use case: A physician investor syndicate evaluating sepsis, fertility, diagnostics, or medical device opportunities.

Buyer titles

Syndicate LeadManaging MemberPhysician InvestorInvestment Committee Chair

Priority 5

Biotech Startups Raising Capital

Make your science easier to understand, trust, and fund.

Core pain: Their science is often complex to communicate and investors need clearer evidence of investability.

Best offer: Fundraising Evidence Atlas

Use case: A platform biotech needs to explain its mechanism, evidence, IP, market, and strategic relevance in one credible interface.

Buyer titles

CEOFounderCSOHead of BDFractional CFO

Priority 6

Pharma and Biotech Business Development Teams

Turn scattered landscape research into a reusable strategic intelligence asset.

Core pain: They need reusable, high-trust landscape intelligence for emerging scientific categories.

Best offer: Strategic Landscape Atlas

Use case: A BD team evaluating RNA delivery, exosome manufacturing, cell therapy tooling, or AI-enabled drug discovery.

Buyer titles

VP Business DevelopmentSearch and Evaluation LeadExternal Innovation LeadStrategy Director

How it works

Step 1

Define the scope

Pick one category thesis, one live deal, or both. We align on decision questions, audience, and target outputs before work starts.

Step 2

Build and review the evidence base

We assemble papers, patents, trials, companies, and market signals, then run human review to keep claims auditable and decision-relevant.

Step 3

Structure the diligence

Evidence is organized into claims, risks, comparables, and investment implications so teams can evaluate quickly and consistently.

Step 4

Publish public and private layers

Outputs are published as branded, crawlable authority pages plus private deal-support views for IC and co-investor workflows.

Step 5

Run as an operating system

Use the atlas in founder, LP, and syndication conversations while reusing the same evidence spine for ongoing diligence and updates.

Service modules

Diligence Engine

AI-assisted and human-reviewed research across science, patents, trials, companies, and markets.

Produces decision-ready evidence that can be audited and reused.

Evidence Graph

A structured map of claims, sources, companies, mechanisms, risks, and investment implications.

Gives teams one searchable source of truth instead of fragmented notes.

Authority Interface

A branded research interface with public and private views tailored to each audience.

Makes diligence usable in real workflows: IC, LP updates, founder discussions, and syndication.

SEO and GEO Layer

Crawlable pages, structured data, internal links, citations, and AI-readable summaries.

Turns diligence output into discoverable authority that compounds over time.

Example categories

Extracellular vesicle therapeuticsIAIP for sepsisAI pathologyNeuroinflammation therapeuticsLongevity biomarkersRNA deliveryFertility diagnosticsCell therapy manufacturingOrgan-on-chip modelsMicrobiome therapeutics

Public layer

Establish visible authority.

  • Category overview
  • Key facts
  • Market map
  • Company profiles
  • Technology explainers
  • Evidence summaries
  • Source-backed thesis pages

Private layer

Support investment decisions.

  • Investment conclusion
  • Bull/base/bear case
  • Risk scoring
  • Target prioritization
  • Deal comparables
  • Decisive experiments
  • Proprietary reviewer notes

What clients receive

Branded Authority Atlas with public and private views
Fund-thesis and/or deal-specific authority pages
Structured claim ledger with source citations
Risk matrix and key underwriting questions
Patent, trial, and competitor landscape summary
Investment implications summary for internal and external communication
Searchable source library
SEO/GEO-ready structured page architecture

Pilot packages

Authority Sprint

$10,000-$20,000

Family offices, emerging funds, and syndicates validating one priority thesis in 4-6 weeks.

  • One scoped thesis with decision questions
  • Core evidence atlas
  • Public authority pages
  • Private investment summary

Single Deal Authority Pack

$12,000-$30,000

Funds and syndicates that need one live deal translated into a clear, citation-backed communication and diligence asset.

  • Deal-specific diligence synthesis
  • Claim and risk ledger for one opportunity
  • Private IC/co-investor decision layer
  • Public-facing authority view and GEO/SEO-ready architecture

Category Authority Atlas

$25,000-$50,000

Funds or family offices building durable category association and reusable diligence infrastructure.

  • Expanded diligence corpus
  • Company landscape
  • Patent/trial/paper mapping
  • Public and private interface
  • SEO/GEO authority architecture

Regional Innovation Atlas

$40,000-$100,000

SSBCI funds, state funds, and ecosystem organizations.

  • Regional company landscape
  • Technology maps
  • Sector thesis pages
  • Public ecosystem authority site
  • Stakeholder-ready reporting layer

Ongoing Monitoring

$3,000-$8,000/month

Clients who want continued category tracking.

  • Monthly updates
  • New papers/patents/trials
  • Company movements
  • Investment signal monitoring
  • Atlas updates

Different from reports, SEO agencies, and AI summaries

Traditional diligence memo

Limitation: Useful internally but usually invisible externally.

Biotica: Creates both private decision support and public authority.

SEO agency

Limitation: Optimizes content without necessarily understanding the science or investment logic.

Biotica: Builds authority from actual diligence.

AI research report

Limitation: Fast but often generic, hard to audit, and not designed for durable visibility.

Biotica: Structures claims, sources, risks, and implications into a reusable evidence asset.

Static PDF

Limitation: Hard to update, hard to crawl, and hard for AI systems to interpret.

Biotica: Publishes structured, crawlable, citation-backed pages.

Own the niche before it gets crowded.

If your firm is exploring a scientific or technology category, Biotica can help you become visibly associated with that category before larger firms dominate the conversation. The first movers in obscure but valuable niches may earn disproportionate credibility.

Start with one thesis.

Choose one scientific thesis, one live deal, or both. We will convert your diligence into a public/private authority atlas that supports decision-making now and discoverability over time.